Roca Therapeutics
Advancing medicine to combat severe, life-threatening diseases caused by hypervascularization and macrophage-induced immunosuppression.
Advancing medicine to combat severe, life-threatening diseases caused by hypervascularization and macrophage-induced immunosuppression.
Roca Therapeutics is a biotechnology startup established in 2021, with a mission to advance the field of medicine in combatting severe, life-threatening diseases. The company's focus lies in developing small medicines targeting diseases caused by hypervascularization and the immunosuppression induced by macrophages M2. Roca Therapeutics' recent milestone includes a Seed Round investment received on 22 September 2022, with participation from 3B Future Health Fund and SATT Sud-Est. The startup operates at the intersection of the Biotechnology and Health and Wellness industries, with a unique emphasis on addressing critical medical challenges through innovative pharmaceutical solutions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 2 |
|
22 Sep 2022 |
No recent news or press coverage available for Roca Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
